Pactiv Evergreen (PTVE) – Research Analysts’ Weekly Ratings Updates

Several analysts have recently updated their ratings and price targets for Pactiv Evergreen (NASDAQ: PTVE): 3/4/2024 – Pactiv Evergreen had its “outperform” rating reaffirmed by analysts at Royal Bank of Canada. They now have a $18.00 price target on the stock. 3/4/2024 – Pactiv Evergreen had its price target raised by analysts at Robert W. […]

Leave a Reply

Your email address will not be published.

Previous post Atara Biotherapeutics (NASDAQ:ATRA) Lowered to “Sell” at StockNews.com
Next post Paramount Global (NASDAQ:PARA) Upgraded to “Hold” by StockNews.com